Campylobacter infection and Guillain - Barré syndrome: Public health concerns from a microbial food safety perspective

Clinical and Applied Immunology Reviews

Volumn 5, Issue 5, 2005, Pages 285-305

  Yan, S Steve ^a   Pendrak, Michael L ^b   Foley, Steven L ^c   Powers, John H ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c UNIVERSITY OF CENTRAL ARKANSAS   (United States)

Author keywords

Antiganglioside antibodies; Antimicrobial resistance; Campylobacter; Campylobacteriosis; Food safety; Guillain Barr syndrome; Monitoring program; Public health

Indexed keywords

AMPICILLIN; ANTIINFECTIVE AGENT; AZITHROMYCIN; BETA LACTAM ANTIBIOTIC; CEPHALOSPORIN DERIVATIVE; CHLORAMPHENICOL; CIPROFLOXACIN; DOXYCYCLINE; ERYTHROMYCIN; GENTAMICIN; IMIPENEM; MACROLIDE; PENICILLIN DERIVATIVE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TETRACYCLINE;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; AUTOIMMUNE DISEASE; BACTERIAL TRANSMISSION; BACTERIUM ISOLATE; CAMPYLOBACTER; CAMPYLOBACTER JEJUNI; CLINICAL FEATURE; DEVELOPED COUNTRY; DIARRHEA; DISEASE ASSOCIATION; FLACCID PARALYSIS; FOOD CONTAMINATION; FOOD SAFETY; GRAM NEGATIVE INFECTION; GUILLAIN BARRE SYNDROME; HEALTH PROGRAM; HUMAN; INFECTION CONTROL; MONITORING; NONHUMAN; PATHOGENESIS; PREVALENCE; PRIORITY JOURNAL; PUBLIC HEALTH; REVIEW;

EID: 29944439251     PISSN: 15291049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cair.2005.08.001     Document Type: Review

References (157)

1. I. Nachamkin B.M. Allos T.W. Ho Campylobacter jejuni infection and the association with Guillain - Barré syndrome In: I. Nachamkin M.J. Blaser editors. Campylobacter 2000 ASM Press Washington, DC 155-175
2. I. Nachamkin B.M. Allos T. Ho Campylobacter species and Guillain - Barre syndrome Clin Microbiol Rev 11 3 1998 555-567
3. K. Ogawara S. Kuwabara M. Mori T. Hattori M. Koga N. Yuki Axonal Guillain - Barre syndrome: Relation to anti-ganglioside antibodies and Campylobacter jejuni infection in Japan Ann Neurol 48 4 2000 624-631
4. M. Koga N. Yuki K. Hirata Antecedent symptoms in Guillain - Barre syndrome: An important indicator for clinical and serological subgroups Acta Neurol Scand 103 5 2001 278-287
5. Buzby J.C., Roberts T., Allos B.M. Estimated annual costs of Campylobacter-associated Guillain - Barre syndrome. Agricultural Economics Report No. (AER756). Washington, DC: US Department of Agriculture; 1997.
6. M.C. Samuel D.J. Vugia S. Shallow R. Marcus S. Segler T. McGivern et al. Epidemiology of sporadic Campylobacter infection in the United States and declining trend in incidence, FoodNet 1996-1999 Clin Infect Dis 38 Suppl. 3 2004 S165-S174
7. Preliminary FoodNet data on the incidence of foodborne illnesses - selected sites, United States, 2002 MMWR Morb Mortal Wkly Rep 52 15 2003 340-343
8. P.S. Mead L. Slutsker V. Dietz L.F. McCaig J.S. Bresee C. Shapiro et al. Food-related illness and death in the United States Emerging Infect Dis 5 5 1999 607-625
9. S.F. Park The physiology of Campylobacter species and its relevance to their role as foodborne pathogens Int J Food Microbiol 74 3 2002 177-188
10. I. Nachamkin Campylobacter and Arcobacter In: P.R. Murray E.J. Baron M.A. Pfaller J.H. Jorgensen R.H. Yolken editors. Manual of clinical microbiology 2003 ASM Press Washington, DC 902-914
11. S.F. Altekruse L.K. Tollefson Human campylobacteriosis: A challenge for the veterinary profession J Am Vet Med Assoc 223 4 2003 445-452
12. P. Silley Campylobacter and fluoroquinolones: A bias data set? Environ Microbiol 5 4 2003 219-230
13. M.J. Sellars S.J. Hall D.J. Kelly Growth of Campylobacter jejuni supported by respiration of fumarate, nitrate, nitrite, trimethylamine-N-oxide, or dimethyl sulfoxide requires oxygen J Bacteriol 184 15 2002 4187-4196
14. N. Dorrell J.A. Mangan K.G. Laing J. Hinds D. Linton H. Al-Ghusein et al. Whole genome comparison of Campylobacter jejuni human isolates using a low-cost microarray reveals extensive genetic diversity Genome Res 11 10 2001 1706-1715
15. E.E. Leonard 2nd T. Takata M.J. Blaser S. Falkow L.S. Tompkins E.C. Gaynor Use of an open-reading frame-specific Campylobacter jejuni DNA microarray as a new genotyping tool for studying epidemiologically related isolates J Infect Dis 187 4 2003 691-694
16. S. Bereswill M. Kist Recent developments in Campylobacter pathogenesis Curr Opin Infect Dis 16 5 2003 487-491
17. A.V. Karlyshev D. Linton N.A. Gregson B.W. Wren A novel paralogous gene family involved in phase-variable flagella-mediated motility in Campylobacter jejuni Microbiology 148 Pt 2 2002 473-480
18. R.L. Ziprin C.R. Young J.A. Byrd L.H. Stanker M.E. Hume S.A. Gray et al. Role of Campylobacter jejuni potential virulence genes in cecal colonization Avian Dis 45 3 2001 549-557
19. M.R. Monteville J.E. Yoon M.E. Konkel Maximal adherence and invasion of INT 407 cells by Campylobacter jejuni requires the CadF outer-membrane protein and microfilament reorganization Microbiology 149 Pt 1 2003 153-165
20. P.T. Richardson S.F. Park Enterochelin acquisition in Campylobacter coli: Characterization of components of a binding-protein-dependent transport system Microbiology 141 Pt 12 1995 3181-3191
21. C.L. Pickett C.A. Whitehouse The cytolethal distending toxin family Trends Microbiol 7 7 1999 292-297
22. M.J. Blaser Epidemiologic and clinical features of Campylobacter jejuni infections J Infect Dis 176 Suppl. 2 1997 S103-S105
23. M.J. Blaser Campylobacter and related species In: G.L. Mandell J.E. Bennett R. Dolin editors. Principles and practice of infectious diseases vol. 2 1995 Churchill Livingstone New York, NY 1948-1956
24. D.W. Chui R.L. Owen AIDS and the gut J Gastroenterol Hepatol 9 3 1994 291-303
25. R.E. Black M.M. Levine M.L. Clements T.P. Hughes M.J. Blaser Experimental Campylobacter jejuni infection in humans J Infect Dis 157 3 1988 472-479
26. M.J. Blaser Infections due to Campylobacter and related species In: E. Braunwald A.S. Fauci K.J. Isselbacher D.L. Kasper S.L. Hauser D.L. Longo J.J. L. editors. Harrison's principles of internal medicine 2001 The McGraw-Hill Companies
27. P.F. McDermott S.M. Bodeis L.L. English D.G. White R.D. Walker S. Zhao et al. Ciprofloxacin resistance in Campylobacter jejuni evolves rapidly in chickens treated with fluoroquinolones J Infect Dis 185 6 2002 837-840
28. A. Hakanen H. Jousimies-Somer A. Siitonen P. Huovinen P. Kotilainen Fluoroquinolone resistance in Campylobacter jejuni isolates in travelers returning to Finland: Association of ciprofloxacin resistance to travel destination Emerging Infect Dis 9 2 2003 267-270
29. P.N. Gaunt L.J. Piddock Ciprofloxacin resistant Campylobacter spp. in humans: An epidemiological and laboratory study J Antimicrob Chemother 37 4 1996 747-757
30. I. Nachamkin H. Ung M. Li Increasing fluoroquinolone resistance in Campylobacter jejuni, Pennsylvania, USA, 1982-2001 Emerging Infect Dis 8 12 2002 1501-1503
31. P. Luber J. Wagner H. Hahn E. Bartelt Antimicrobial resistance in Campylobacter jejuni and Campylobacter coli strains isolated in 1991 and 2001-2002 from poultry and humans in Berlin, Germany Antimicrob Agents Chemother 47 12 2003 3825-3830
32. L.J. Piddock V. Ricci L. Pumbwe M.J. Everett D.J. Griggs Fluoroquinolone resistance in Campylobacter species from man and animals: Detection of mutations in topoisomerase genes J Antimicrob Chemother 51 1 2003 19-26
33. J.A. Adachi L. Ostrosky-Zeichner H.L. DuPont C.D. Ericsson Empirical antimicrobial therapy for traveler's diarrhea Clin Infect Dis 31 4 2000 1079-1083
34. J. Engberg F.M. Aarestrup D.E. Taylor P. Gerner-Smidt I. Nachamkin Quinolone and macrolide resistance in Campylobacter jejuni and C. coli: resistance mechanisms and trends in human isolates Emerging Infect Dis 7 1 2001 24-34
35. M.B. Skirrow M.J. Blaser Clinical aspects of Campylobacter infection In: I. Nachamkin M.J. Blaser editors. Campylobacter 2000 ASM Press Washington, DC 69-88
36. B. Amor Reiter's syndrome. Diagnosis and clinical features Rheum Dis Clin North Am 24 4 1998 677-695
37. J.T. Kirchner Reiter's syndrome. A possibility in patients with reactive arthritis Postgrad Med 97 3 1995 111-112
38. J.D. Reveille HLA-B27 and the seronegative spondyloarthropathies Am J Med Sci 316 4 1998 239-249
39. I. Nachamkin Chronic effects of Campylobacter infection Microbes Infect 4 4 2002 399-403
40. A.K. Asbury S.L. Hauser Guillain - Barre syndrome and other immune-mediated neuropathies In: E. Braunwald A.S. Fauci K.J. Isselbacher D.L. Kasper S.L. Hauser D.L. Longo J.J. L. editors. Harrison's principles of internal medicine 2001 The McGraw-Hill Companies
41. F.G. Van der Meche P.A. Van Doorn J. Meulstee F.G. Jennekens Diagnostic and classification criteria for the Guillain - Barre syndrome Eur Neurol 45 3 2001 133-139
42. S. Kuwabara Guillain - Barre syndrome: Epidemiology, pathophysiology and management Drugs 64 6 2004 597-610
43. A.K. Asbury New concepts of Guillain - Barre syndrome J Child Neurol 15 3 2000 183-191
44. V. Govoni E. Granieri Epidemiology of the Guillain - Barre syndrome Curr Opin Neurol 14 5 2001 605-613
45. J. Engberg I. Nachamkin V. Fussing G.M. McKhann J.W. Griffin J.C. Piffaretti et al. Absence of clonality of Campylobacter jejuni in serotypes other than HS:19 associated with Guillain - Barre syndrome and gastroenteritis J Infect Dis 184 2 2001 215-220
46. A.K. Asbury D.R. Cornblath Assessment of current diagnostic criteria for Guillain-Barre syndrome Ann Neurol 27 Suppl. 1990 S21-S24
47. I. Nachamkin H. Ung A.P. Moran D. Yoo M.M. Prendergast M.A. Nicholson et al. Ganglioside GM1 mimicry in Campylobacter strains from sporadic infections in the United States J Infect Dis 179 5 1999 1183-1189
48. J.H. Rees S.E. Soudain N.A. Gregson R.A. Hughes Campylobacter jejuni infection and Guillain - Barre syndrome N Engl J Med 333 21 1995 1374-1379
49. B.C. Jacobs P.H. Rothbarth F.G. van der Meche P. Herbrink P.I. Schmitz M.A. de Klerk et al. The spectrum of antecedent infections in Guillain-Barre syndrome: A case-control study Neurology 51 4 1998 1110-1115
50. C.W. Ang P.A. van Doorn H.P. Endtz I.S. Merkies B.C. Jacobs M.A. de Klerk et al. A case of Guillain - Barre syndrome following a family outbreak of Campylobacter jejuni enteritis J Neuroimmunol 111 1-2 2000 229-233
51. N. Yuki H. Yoshino S. Sato T. Miyatake Acute axonal polyneuropathy associated with anti-GM1 antibodies following Campylobacter enteritis Neurology 40 12 1990 1900-1902
52. R.S. Tsang The relationship of Campylobacter jejuni infection and the development of Guillain - Barre syndrome Curr Opin Infect Dis 15 3 2002 221-228
53. N. Yuki Infectious origins of, and molecular mimicry in, Guillain - Barre and Fisher syndromes Lancet Infect Dis 1 1 2001 29-37
54. P. Guerry C.P. Ewing T.E. Hickey M.M. Prendergast A.P. Moran Sialylation of lipooligosaccharide cores affects immunogenicity and serum resistance of Campylobacter jejuni Infect Immun 68 12 2000 6656-6662
55. I. Nachamkin J. Liu M. Li H. Ung A.P. Moran M.M. Prendergast et al. Campylobacter jejuni from patients with Guillain - Barre syndrome preferentially expresses a GD(1a)-like epitope Infect Immun 70 9 2002 5299-5303
56. T.W. Ho H.J. Willison I. Nachamkin C.Y. Li J. Veitch H. Ung et al. Anti-GD1a antibody is associated with axonal but not demyelinating forms of Guillain-Barre syndrome Ann Neurol 45 2 1999 168-173
57. C.W. Ang M.A. De Klerk H.P. Endtz B.C. Jacobs J.D. Laman F.G. van der Meche et al. Guillain - Barre syndrome- and Miller Fisher syndrome-associated Campylobacter jejuni lipopolysaccharides induce anti-GM1 and anti-GQ1b antibodies in rabbits Infect Immun 69 4 2001 2462-2469
58. I. Nachamkin J. Engberg M. Gutacker R.J. Meinersman C.Y. Li P. Arzate et al. Molecular population genetic analysis of Campylobacter jejuni HS:19 associated with Guillain-Barre syndrome and gastroenteritis J Infect Dis 184 2 2001 221-226
59. S. Sinha K.N. Prasad S. Pradhan D. Jain S. Jha Detection of preceding Campylobacter jejuni infection by polymerase chain reaction in patients with Guillain - Barre syndrome Trans R Soc Trop Med Hyg 98 6 2004 342-346
60. J.L. Penner J.N. Hennessy Passive hemagglutination technique for serotyping Campylobacter fetus subsp. jejuni on the basis of soluble heat-stable antigens J Clin Microbiol 12 6 1980 732-737
61. H. Lior D.L. Woodward J.A. Edgar L.J. Laroche P. Gill Serotyping of Campylobacter jejuni by slide agglutination based on heat-labile antigenic factors J Clin Microbiol 15 5 1982 761-768
62. H. Lior D.L. Woodward J.A. Edgar L.J. LaRoche Serotyping by slide agglutination of Campylobacter jejuni and epidemiology Lancet 2 8255 1981 1103-1104
63. D.M. Jones E.M. Sutcliffe J.D. Abbott Serotyping of Campylobacter species by combined use of two methods Eur J Clin Microbiol 4 6 1985 562-565
64. H.P. Hartung B.C. Kieseier R. Kiefer Progress in Guillain - Barre syndrome Curr Opin Neurol 14 5 2001 597-604
65. C. Museteanu G. Henneberg Robert Koch's unpublished and unfinished experiments on sheep-pox [author's transl] Zentralbl Bakteriol [Orig A] 236 2-3 1976 205-214
66. C.R. Friedman R.M. Hoekstra M. Samuel R. Marcus J. Bender B. Shiferaw et al. Risk factors for sporadic Campylobacter infection in the United States: A case-control study in FoodNet sites Clin Infect Dis 38 Suppl. 3 2004 S285-S296
67. M.B. Skirrow Campylobacter Lancet 336 8720 1990 921-923
68. P. Effler M.C. Ieong A. Kimura M. Nakata R. Burr E. Cremer et al. Sporadic Campylobacter jejuni infections in Hawaii: Associations with prior antibiotic use and commercially prepared chicken J Infect Dis 183 7 2001 1152-1155
69. C.M. Logue J.S. Sherwood L.M. Elijah P.A. Olah M.R. Dockter The incidence of Campylobacter spp. on processed turkey from processing plants in the midwestern United States J Appl Microbiol 95 2 2003 234-241
70. E.M. Nielsen J. Engberg M. Madsen Distribution of serotypes of Campylobacter jejuni and C. coli from Danish patients, poultry, cattle and swine FEMS Immunol Med Microbiol 19 1 1997 47-56
71. T.J. Humphrey P. Beckett Campylobacter jejuni in dairy cows and raw milk Epidemiol Infect 98 3 1987 263-269
72. J.A. Korlath M.T. Osterholm L.A. Judy J.C. Forfang R.A. Robinson A point-source outbreak of campylobacteriosis associated with consumption of raw milk J Infect Dis 152 3 1985 592-596
73. B.E. Rice D.M. Rollins E.T. Mallinson L. Carr S.W. Joseph Campylobacter jejuni in broiler chickens: Colonization and humoral immunity following oral vaccination and experimental infection Vaccine 15 17-18 1997 1922-1932
74. C.W. Lin P.L. Yin K.S. Cheng Incidence and clinical manifestations of Campylobacter enteritis in central Taiwan Zhonghua Yi Xue Za Zhi (Taipei) 61 6 1998 339-345
75. CDC Accessed 07.01.05
76. K.N. Prasad A.K. Dixit A. Ayyagari Campylobacter species associated with diarrhoea in patients from a tertiary care centre of north India Indian J Med Res 114 2001 12-17
77. L. Bodhidatta N. Vithayasai B. Eimpokalarp C. Pitarangsi O. Serichantalergs D.W. Isenbarger Bacterial enteric pathogens in children with acute dysentery in Thailand: Increasing importance of quinolone-resistant Campylobacter Southeast Asian J Trop Med Public Health 33 4 2002 752-757
78. C.R. Young R. Harvey R. Anderson D. Nisbet L.H. Stanker Enteric colonisation following natural exposure to Campylobacter in pigs Res Vet Sci 68 1 2000 75-78
79. R.B. Harvey R.C. Anderson C.R. Young M.E. Hume K.J. Genovese R.L. Ziprin et al. Prevalence of Campylobacter, Salmonella, and Arcobacter species at slaughter in market age pigs Adv Exp Med Biol 473 1999 237-239
80. S.F. Altekruse J.M. Hunt L.K. Tollefson J.M. Madden Food and animal sources of human Campylobacter jejuni infection J Am Vet Med Assoc 204 1 1994 57-61
81. E. Gregory H. Barnhart D.W. Dreesen N.J. Stern J.L. Corn Epidemiological study of Campylobacter spp. in broilers: Source, time of colonization, and prevalence Avian Dis 41 4 1997 890-898
82. S.M. Moorhead G.A. Dykes Survival of Campylobacter jejuni on beef trimmings during freezing and frozen storage Lett Appl Microbiol 34 1 2002 72-76
83. FDA-CVM Accessed 07.01.05
84. K.E. Smith J.M. Besser C.W. Hedberg F.T. Leano J.B. Bender J.H. Wicklund et al. Quinolone-resistant Campylobacter jejuni infections in Minnesota, 1992-1998. Investigation Team N Engl J Med 340 20 1999 1525-1532
85. C. Zhao B. Ge J. De Villena R. Sudler E. Yeh S. Zhao Prevalence of Campylobacter spp., Escherichia coli, and Salmonella serovars in retail chicken, turkey, pork, and beef from the Greater Washington, D.C., area Appl Environ Microbiol 67 12 2001 5431-5436
86. A. De Cesare B.W. Sheldon K.S. Smith L.A. Jaykus Survival and persistence of Campylobacter and Salmonella species under various organic loads on food contact surfaces J Food Prot 66 9 2003 1587-1594
87. C.M. Moore B.W. Sheldon L.A. Jaykus Transfer of Salmonella and Campylobacter from stainless steel to romaine lettuce J Food Prot 66 12 2003 2231-2236
88. H.D. Kusumaningrum G. Riboldi W.C. Hazeleger R.R. Beumer Survival of foodborne pathogens on stainless steel surfaces and cross-contamination to foods Int J Food Microbiol 85 3 2003 227-236
89. C.A. Phillips Incidence of Campylobacter and possible modes of transmission Nutr Food Sci 95 1995 12-17
90. C.G. Clark L. Price R. Ahmed D.L. Woodward P.L. Melito F.G. Rodgers et al. Characterization of waterborne outbreak-associated Campylobacter jejuni, Walkerton, Ontario Emerging Infect Dis 9 10 2003 1232-1241
91. H. Lindmark B. Harbom L. Thebo L. Andersson G. Hedin B. Osterman et al. Genetic characterization and antibiotic resistance of Campylobacter jejuni isolated from meats, water, and humans in Sweden J Clin Microbiol 42 2 2004 700-706
92. H. Auld D. MacIver J. Klaassen Heavy rainfall and waterborne disease outbreaks: The Walkerton example J Toxicol Environ Health A 67 20-22 2004 1879-1887
93. R. Eyles D. Niyogi C. Townsend G. Benwell P. Weinstein Spatial and temporal patterns of Campylobacter contamination underlying public health risk in the Taieri River, New Zealand J Environ Qual 32 5 2003 1820-1828
94. W. Baffone F. Bruscolini A. Pianetti M.R. Biffi G. Brandi L. Salvaggio et al. Diffusion of thermophilic Campylobacter in the Pesaro-Urbino area (Italy) from 1985 to 1992 Eur J Epidemiol 11 1 1995 83-86
95. C. Bates K.L. Hiett N.J. Stern Relationship of Campylobacter isolated from poultry and from darkling beetles in New Zealand Avian Dis 48 1 2004 138-147
96. J.E. Moore D. Gilpin E. Crothers A. Canney A. Kaneko M. Matsuda Occurrence of Campylobacter spp. and Cryptosporidium spp. in seagulls (Larus spp.) Vector Borne Zoonotic Dis 2 2 2002 111-114
97. N.A. Luechtefeld M.J. Blaser L.B. Reller W.L. Wang Isolation of Campylobacter fetus subsp. jejuni from migratory waterfowl J Clin Microbiol 12 3 1980 406-408
98. L. Tollefson F.J. Angulo P.J. Fedorka-Cray National surveillance for antibiotic resistance in zoonotic enteric pathogens Vet Clin N Am Food Anim Pract 14 1 1998 141-150
99. E. Charvalos Y. Tselentis M.M. Hamzehpour T. Kohler J.C. Pechere Evidence for an efflux pump in multidrug-resistant Campylobacter jejuni Antimicrob Agents Chemother 39 9 1995 2019-2022
100. F.M. Aarestrup F. Bager N.E. Jensen M. Madsen A. Meyling H.C. Wegener Resistance to antimicrobial agents used for animal therapy in pathogenic-, zoonotic- and indicator bacteria isolated from different food animals in Denmark: A baseline study for the Danish Integrated Antimicrobial Resistance Monitoring Programme (DANMAP) APMIS 106 8 1998 745-770
101. A.J. Hakanen M. Lehtopolku A. Siitonen P. Huovinen P. Kotilainen Multidrug resistance in Campylobacter jejuni strains collected from Finnish patients during 1995-2000 J Antimicrob Chemother 52 6 2003 1035-1039
102. D.G. White S. Zhao S. Simjee D.D. Wagner P.F. McDermott Antimicrobial resistance of foodborne pathogens Microbes Infect 4 4 2002 405-412
103. K. Travers M. Barza Morbidity of infections caused by antimicrobial-resistant bacteria Clin Infect Dis 34 Suppl. 3 2002 S131-S134
104. A. Hakanen P. Huovinen P. Kotilainen A. Siitonen H. Jousimies-Somer Quality control strains used in susceptibility testing of Campylobacter spp J Clin Microbiol 40 7 2002 2705-2706
105. P.F. McDermott S.M. Bodeis F.M. Aarestrup S. Brown M. Traczewski P. Fedorka-Cray et al. Development of a standardized susceptibility test for Campylobacter with quality-control ranges for ciprofloxacin, doxycycline, erythromycin, gentamicin, and meropenem Microb Drug Resist 10 2 2004 124-131
106. C.L. Hayward M.E. Erwin M.S. Barrett R.N. Jones Comparative antimicrobial activity of gatifloxacin tested against Campylobacter jejuni including fluoroquinolone-resistant clinical isolates Diagn Microbiol Infect Dis 34 2 1999 99-102
107. J. Engberg S. Andersen R. Skov F.M. Aarestrup P. Gerner-Smidt Comparison of two agar dilution methods and three agar diffusion methods, including the Etest, for antibiotic susceptibility testing of thermophilic Campylobacter species Clin Microbiol Infect 5 9 1999 580-584
108. O. Oncul P. Zarakolu D. Gur Antimicrobial susceptibility testing of Campylobacter jejuni: A comparison between Etest and agar dilution method Diagn Microbiol Infect Dis 45 1 2003 69-71
109. B. Ge S. Bodeis R.D. Walker D.G. White S. Zhao P.F. McDermott et al. Comparison of the Etest and agar dilution for in vitro antimicrobial susceptibility testing of Campylobacter J Antimicrob Chemother 50 4 2002 487-494
110. P. Tajada J.L. Gomez-Graces J.I. Alos D. Balas R. Cogollos Antimicrobial susceptibilities of Campylobacter jejuni and Campylobacter coli to 12 beta-lactam agents and combinations with beta-lactamase inhibitors Antimicrob Agents Chemother 40 8 1996 1924-1925
111. L.P. Randall A.M. Ridley S.W. Cooles M. Sharma A.R. Sayers L. Pumbwe et al. Prevalence of multiple antibiotic resistance in 443 Campylobacter spp. isolated from humans and animals J Antimicrob Chemother 52 3 2003 507-510
112. J. Lin L.O. Michel Q. Zhang CmeABC functions as a multidrug efflux system in Campylobacter jejuni Antimicrob Agents Chemother 46 7 2002 2124-2131
113. A.M. Sefton Mechanisms of antimicrobial resistance: Their clinical relevance in the new millennium Drugs 62 4 2002 557-566
114. J.G. Hardman L.E. Limbird P.B. Molinoff R.W. Ruddon A.G. Gilman Goodman & Gilman's the pharmacological basis of therapeutics 1996 McGraw-Hill New York
115. G. Funke R. Baumann J.L. Penner M. Altwegg Development of resistance to macrolide antibiotics in an AIDS patient treated with clarithromycin for Campylobacter jejuni diarrhea Eur J Clin Microbiol Infect Dis 13 7 1994 612-615
116. W. Yan D.E. Taylor Characterization of erythromycin resistance in Campylobacter jejuni and Campylobacter coli Antimicrob Agents Chemother 35 10 1991 1989-1996
117. E.J. Kuijper S. Stevens T. Imamura B. De Wever E.C. Claas Genotypic identification of erythromycin-resistant Campylobacter isolates as Helicobacter species and analysis of resistance mechanism J Clin Microbiol 41 8 2003 3732-3736
118. L. Pumbwe L.P. Randall M.J. Woodward L.J. Piddock Expression of the efflux pump genes cmeB, cmeF and the porin gene porA in multiple-antibiotic-resistant Campylobacter jejuni J Antimicrob Chemother 2004
119. L. Mamelli J.P. Amoros J.M. Pages J.M. Bolla A phenylalanine-arginine beta-naphthylamide sensitive multidrug efflux pump involved in intrinsic and acquired resistance of Campylobacter to macrolides Int J Antimicrob Agents 22 3 2003 237-241
120. CDC Accessed 07.01.05
121. S.D. Putnam R.W. Frenck M.S. Riddle A. El-Gendy N.N. Taha B.T. Pittner et al. Antimicrobial susceptibility trends in Campylobacter jejuni and Campylobacter coli isolated from a rural Egyptian pediatric population with diarrhea Diagn Microbiol Infect Dis 47 4 2003 601-608
122. L.B. Jensen F.M. Aarestrup Macrolide resistance in Campylobacter coli of animal origin in Denmark Antimicrob Agents Chemother 45 1 2001 371-372
123. L. Tollefson P.J. Fedorka-Cray F.J. Angulo Public health aspects of antibiotic resistance monitoring in the USA Acta Vet Scand Suppl 92 1999 67-75
124. N.N. Marano S. Rossiter K. Stamey K. Joyce T.J. Barrett L.K. Tollefson et al. The National Antimicrobial Resistance Monitoring System (NARMS) for enteric bacteria, 1996-1999: Surveillance for action J Am Vet Med Assoc 217 12 2000 1829-1830
125. B. Ge D.G. White P.F. McDermott W. Girard S. Zhao S. Hubert et al. Antimicrobial-resistant Campylobacter species from retail raw meats Appl Environ Microbiol 69 5 2003 3005-3007
126. Rossiter S, Joyce K, Ray M, Benson J, Mackinson C, Gregg C, et al. High prevalence of fluoroquinolone-resistant Campylobacter jejuni in the FoodNet Sites: A hazard in the food supply. In: International conference on emerging infectious diseases, Atlanta, GA; 2000.
127. H. Rosenquist N.L. Nielsen H.M. Sommer B. Norrung B.B. Christensen Quantitative risk assessment of human campylobacteriosis associated with thermophilic Campylobacter species in chickens Int J Food Microbiol 83 1 2003 87-103
128. D.R. Hendrixson V.J. DiRita Identification of Campylobacter jejuni genes involved in commensal colonization of the chick gastrointestinal tract Mol Microbiol 52 2 2004 471-484
129. Q. Zhang J. Lin S. Pereira Fluoroquinolone-resistant Campylobacter in animal reservoirs: Dynamics of development, resistance mechanisms and ecological fitness Anim Health Res Rev 4 2 2003 63-71
130. T.D. Gootz B.A. Martin Characterization of high-level quinolone resistance in Campylobacter jejuni Antimicrob Agents Chemother 35 5 1991 840-845
131. M. Oethinger W.V. Kern A.S. Jellen-Ritter L.M. McMurry S.B. Levy Ineffectiveness of topoisomerase mutations in mediating clinically significant fluoroquinolone resistance in Escherichia coli in the absence of the AcrAB efflux pump Antimicrob Agents Chemother 44 1 2000 10-13
132. D.M. Gilbert R.C. Moellering M.A. Sande editors. The Sanford guide to antimicrobial therapy 2003 Hyde Park, VT
133. D.E. Brodersen W.M. Clemons Jr. A.P. Carter R.J. Morgan-Warren B.T. Wimberly V. Ramakrishnan The structural basis for the action of the antibiotics tetracycline, pactamycin, and hygromycin B on the 30S ribosomal subunit Cell 103 7 2000 1143-1154
134. S.R. Connell C.A. Trieber G.P. Dinos E. Einfeldt D.E. Taylor K.H. Nierhaus Mechanism of Tet(O)-mediated tetracycline resistance EMBO J 22 4 2003 945-953
135. D.J. Bacon R.A. Alm D.H. Burr L. Hu D.J. Kopecko C.P. Ewing et al. Involvement of a plasmid in virulence of Campylobacter jejuni 81-176 Infect Immun 68 8 2000 4384-4390
136. D.E. Taylor P. Courvalin Mechanisms of antibiotic resistance in Campylobacter species Antimicrob Agents Chemother 32 8 1988 1107-1112
137. S.S. Yan M.L. Pendrak B. Abela-Ridder J.W. Punderson D.P. DFedorko S.L. Foley An overview of Salmonella typing: Public health perspectives Clin Appl Immunol Rev 4 2004 189-204
138. CDC Accessed 07.01.05
139. Incidence of foodborne illnesses: Preliminary data from the Foodborne Diseases Active Surveillance Network (FoodNet) - United States, 1998 MMWR Morb Mortal Wkly Rep 48 9 1999 189-194
140. D.J. Karras Incidence of foodborne illnesses: Preliminary data from the foodborne diseases active surveillance network (FoodNet) Ann Emerg Med 35 1 2000 92-93
141. CDC Accessed 07.01.05
142. B. Swaminathan T.J. Barrett S.B. Hunter R.V. Tauxe PulseNet: The molecular subtyping network for foodborne bacterial disease surveillance, United States Emerging Infect Dis 7 3 2001 382-389
143. F. Bager DANMAP: Monitoring antimicrobial resistance in Denmark Int J Antimicrob Agents 14 4 2000 271-274
144. J. Takkinen A. Ammon O. Robstad T. Breuer European survey on Campylobacter surveillance and diagnosis 2001 Euro Surveill 8 11 2003 207-213
145. Global Salm-Surv on Internet Wkly Epidemiol Rec 75 29 2000 236-237
146. Accessed 07.01.05
147. P.J. Quinn B.K. Markey M.E. Carter W.J. Donnelly F.C. Leonard Veterinary microbiology and microbial disease 2002 Blackwell Publishing Malden, MA
148. P.J. Macuch A.C. Tanner Campylobacter species in health, gingivitis, and periodontitis J Dent Res 79 2 2000 785-792
149. P.A. Totten C.L. Fennell F.C. Tenover J.M. Wezenberg P.L. Perine W.E. Stamm et al. Campylobacter cinaedi (sp. nov.) and Campylobacter fennelliae (sp. nov.): Two new Campylobacter species associated with enteric disease in homosexual men J Infect Dis 151 1 1985 131-139
150. M.R. Alderton V. Korolik P.J. Coloe F.E. Dewhirst B.J. Paster Campylobacter hyoilei sp. nov., associated with porcine proliferative enteritis Int J Syst Bacteriol 45 1 1995 61-66
151. M.S. Dep G.L. Mendz M.A. Trend P.J. Coloe B.N. Fry V. Korolik Differentiation between Campylobacter hyoilei and Campylobacter coli using genotypic and phenotypic analyses Int J Syst Evol Microbiol 51 Pt 3 2001 819-826
152. National Library of Medicine Accessed 07.01.05
153. R.L. Guerrant A.A. Lima N.M. Thielman T.S. Steiner M.C. Fonteles Diarrhea, demography and cell signaling: Lessons from microbial toxins Trans Am Clin Climatol Assoc 108 1996 149-162
154. N.M. Thielman R.L. Guerrant Clinical practice. Acute infectious diarrhea N Engl J Med 350 1 2004 38-47
155. R.L. Guerrant T. Van Gilder T.S. Steiner N.M. Thielman L. Slutsker R.V. Tauxe et al. Practice guidelines for the management of infectious diarrhea Clin Infect Dis 32 3 2001 331-351
156. C.F. Lesser S.I. Miller Salmonellosis [on-line edition] In: E. Braunwald A.S. Fauci K.J. Isselbacher D.L. Kasper S.L. Hauser D.L. Longo J.J. L. editors. Harrison's principles of internal medicine 2001 The McGraw-Hill Companies
157. G.T. Keusch Shigellosis [on-line edition] In: E. Braunwald A.S. Fauci K.J. Isselbacher D.L. Kasper S.L. Hauser D.L. Longo J.J. L. editors. Harrison's principles of internal medicine 2001 The McGraw-Hill Companies